One-Step Electrochemically Deposited Nanocomposite Film of CS-Fc/MWNTs/GOD for Glucose Biosensor Application

High-power biofuel cells based on three-dimensional reduced graphene oxide/carbon nanotube micro-arrays

Miniaturized enzymatic biofuel cells (EBFCs) with high cell performance are promising candidates for powering next-generation implantable medical devices. Here, we report a closed-loop theoretical and experimental study on a micro EBFC system based on three-dimensional (3D) carbon micropillar arrays coated with reduced graphene oxide (rGO), carbon nanotubes (CNTs), and a biocatalyst composite. The fabrication process of this system combines the top-down carbon microelectromechanical systems (C-MEMS) technique to fabricate the 3D micropillar array platform and bottom-up electrophoretic deposition (EPD) to deposit the reduced rGO/CNTs/enzyme onto the electrode surface. The Michaelis-Menten constant KM of 2.1 mM for glucose oxidase (GOx) on the rGO/CNTs/GOx bioanode was obtained, which is close to the KM for free GOx. Theoretical modelling of the rGO/CNT-based EBFC system via finite element analysis was conducted to predict the cell performance and efficiency. The experimental results from the developed rGO/CNT-based EBFC showed a maximum power density of 196.04 µW cm-2 at 0.61 V, which is approximately twice the maximum power density obtained from the rGO-based EBFC. The experimental power density is noted to be 71.1% of the theoretical value.

Review of Electrochemically Triggered Macromolecular Film Buildup Processes and Their Biomedical Applications

Macromolecular coatings play an important role in many technological areas, ranging from the car industry to biosensors. Among the different coating technologies, electrochemically triggered processes are extremely powerful because they allow in particular spatial confinement of the film buildup up to the micrometer scale on microelectrodes. Here, we review the latest advances in the field of electrochemically triggered macromolecular film buildup processes performed in aqueous solutions. All these processes will be discussed and related to their several applications such as corrosion prevention, biosensors, antimicrobial coatings, drug-release, barrier properties and cell encapsulation. Special emphasis will be put on applications in the rapidly growing field of biosensors. Using polymers or proteins, the electrochemical buildup of the films can result from a local change of macromolecules solubility, self-assembly of polyelectrolytes through electrostatic/ionic interactions or covalent cross-linking between different macromolecules. The assembly process can be in one step or performed step-by-step based on an electrical trigger affecting directly the interacting macromolecules or generating ionic species.

An ultrasensitive nanobiohybrid platform for glucose electrochemical biosensing based on ferrocenyl iminopropyl-modified silica nanoparticles

A novel nanobiohybrid platform based on ferrocenyl iminopropyl-modified silica nanoparticle conjugates (fap-SiNPs), entrapped in glucose oxidase (GOx) and bovine serum albumin cross-linked with glutaraldehyde, was developed.

Functionalization of monolithic and porous three-dimensional graphene by one-step chitosan electrodeposition for enzymatic biosensor

Biological modification of monolithic and porous 3D graphene is of great significance for extending its application in fabricating highly sensitive biosensors. The present work reports on the first biofunctionalization of monolithic and freestanding 3D graphene foam for one-step preparation of reagentless enzymatic biosensors by controllable chitosan (CS) electrodeposition technology. Using a homogeneous three-component electrodeposition solution containing a ferrocene (Fc) grafted CS hybrid (Fc-CS), glucose oxidase (GOD), and single-walled carbon nanotubes (SWNTs), a homogeneous biocomposite film of Fc-CS/SWNTs/GOD was immobilized on the surface of 3D graphene foam by one-step electrodeposition. The Fc groups grafted on chitosan can be stably immobilized on the 3D graphene surface and keep their original electrochemical activity. The SWNTs doped into the Fc-CS matrix act as a nanowire to facilitate electron transfer and improve the conductivity of the biocomposite film. Combined with the extraordinary properties of 3D graphene foam including large active surface area, high conductivity, and fast mass transport dynamics, the 3D graphene based enzymatic biosensor achieved a large linear range (5.0 μM to 19.8 mM), a low detection limit (1.2 μM), and rapid response (reaching the 95% steady-state response within 8 s) for reagentless detection of glucose in the phosphate buffer solution.

Redox-functionalized graphene oxide architecture for the development of amperometric biosensing platform

We describe the redox functionalization of graphene oxide (GO) and the development of versatile amperometric biosensing platforms for clinically important analytes such as cholesterol ester, uric acid and glucose. Ferrocene (Fc) redox units were covalently tethered onto the GO backbone using diamine sigma spacers of different chain lengths (C3-, C6-, and C9-diamines). The functionalized GO (Fc-GO) displays a pair of redox peak corresponding to Fc/Fc(+) redox couple at ~0.225 V. The surface coverage and heterogeneous electron transfer rate constant of Fc-GO depends on the length of sigma spacer. Amperometric biosensors for cholesterol (total), uric acid and glucose have been developed by integrating Fc-GO and the respective redox enzymes with screen printed electrode. Fc-GO efficiently mediates the bioelectrocatalytic oxidation of the substrates in the presence of the redox enzymes. The spacer length of Fc-GO controls the bioelectrocatalytic response of the biosensing platforms. The sensitivity of the biosensors based on C9 sigma spacer is significantly higher than the others. The detection limit (S/N = 3) of the biosensors for cholesterol and uric acid was 0.1 μM and for glucose it was 1 μM. Excellent stability, reproducibility, selectivity and fast response time were achieved. Biosensing of cholesterol, uric acid and glucose in human serum sample is successfully demonstrated with the biosensors, and the results are validated with the clinical laboratory measurement.

Electrodeposition of a biopolymeric hydrogel: potential for one-step protein electroaddressing

The electrodeposition of hydrogels provides a programmable means to assemble soft matter for various technological applications. We report an anodic method to deposit hydrogel films of the aminopolysaccharide chitosan. Evidence suggests the deposition mechanism involves the electrolysis of chloride to generate reactive chlorine species (e.g., HOCl) that partially oxidize chitosan to generate aldehydes that can couple covalently with amines (presumably through Schiff base linkages). Chitosan's anodic deposition is controllable spatially and temporally. Consistent with a covalent cross-linking mechanism, the deposited chitosan undergoes repeated swelling/deswelling in response to pH changes. Consistent with a covalent conjugation mechanism, proteins could be codeposited and retained within the chitosan film even after detergent washing. As a proof-of-concept, we electroaddressed glucose oxidase to a side-wall electrode of a microfabricated fluidic channel and demonstrated this enzyme could perform electrochemical biosensing functions. Thus, anodic chitosan deposition provides a reagentless, single-step method to electroaddress a stimuli-responsive and biofunctionalized hydrogel film.